Summit Creek Advisors LLC raised its holdings in Transcat, Inc. (NASDAQ:TRNS – Free Report) by 23.8% during the third quarter, HoldingsChannel.com reports. The fund owned 58,135 shares of the scientific and technical instruments company’s stock after purchasing an additional 11,165 shares during the period. Transcat makes up about 2.1% of Summit Creek Advisors LLC’s holdings, making the stock its 22nd biggest holding. Summit Creek Advisors LLC’s holdings in Transcat were worth $5,140,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Wellington Management Group LLP bought a new position in Transcat in the 2nd quarter valued at approximately $29,409,000. Bank of America Corp DE acquired a new stake in Transcat in the second quarter valued at approximately $2,386,000. Bank of New York Mellon Corp acquired a new stake in Transcat in the second quarter valued at approximately $2,742,000. Punch & Associates Investment Management Inc. acquired a new stake in Transcat in the second quarter valued at approximately $7,430,000. Finally, Bamco Inc. NY bought a new stake in shares of Transcat during the second quarter worth $17,649,000. Institutional investors and hedge funds own 98.34% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on TRNS. CJS Securities started coverage on shares of Transcat in a report on Tuesday, October 27th. They set an “outperform” rating and a $115.00 price target for the company. Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday. Oppenheimer upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price objective on the stock in a research report on Wednesday. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Finally, Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $108.33.
Insider Transactions at Transcat
In other Transcat news, CEO Jaime A. Irick purchased 2,275 shares of the company’s stock in a transaction dated Thursday, November 5th. The stock was purchased at an average price of $101.26 per share, with a total value of $230,366.50. Following the completion of the purchase, the chief executive officer owned 2,275 shares of the company’s stock, valued at approximately $230,366.50. The trade was a ? increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.80% of the company’s stock.
Transcat News Roundup
Here are the key news stories impacting Transcat this week:
- Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
- Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
- Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
- Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
- Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target
Transcat Stock Performance
Transcat stock opened at $101.51 on Friday. The business has a 50 day moving average of $86.94 and a 200-day moving average of $82.43. The company has a market capitalization of $954.70 million, a P/E ratio of 211.48 and a beta of 0.61. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $110.47. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.57 and a quick ratio of 2.11.
Transcat (NASDAQ:TRNS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.45 by $0.19. Transcat had a net margin of 1.26% and a return on equity of 6.14%. The business had revenue of $97.09 million for the quarter, compared to the consensus estimate of $92.46 million. On average, equities research analysts predict that Transcat, Inc. will post 2.06 earnings per share for the current year.
Transcat Profile
Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.
Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.
Featured Articles
- Five stocks we like better than Transcat
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
